Maternity - Nursing Case Study
Pathophysiology
• Primary mechanism: Hormonal changes during pregnancy, primarily increased levels of progesterone and estrogen, lead to systemic vasodilation and increased blood volume. This supports fetal development but can contribute to conditions like gestational hypertension or preeclampsia due to an imbalance in vascular resistance.
• Secondary mechanism: Placental development and function are crucial for nutrient exchange between mother and fetus. Inadequate placental perfusion can result in intrauterine growth restriction (IUGR) due to impaired blood flow and nutrient delivery.
• Key complication: Gestational diabetes arises from insulin resistance exacerbated by placental hormones like human placental lactogen, causing hyperglycemia. This can lead to macrosomia (large-for-gestational-age infants) and increase the risk of cesarean delivery.
Patient Profile
Demographics:
32 years old, female, office manager
History:
• Key past medical history: Gestational diabetes in previous pregnancy, hypothyroidism
• Current medications: Levothyroxine 75 mcg daily, prenatal vitamins
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Severe headache and swelling in hands and feet
• Key symptoms: Elevated blood pressure, proteinuria, blurred vision
• Vital signs: Blood pressure 150/95 mmHg, heart rate 92 bpm, respiratory rate 18 breaths per minute, temperature 98.6°F, oxygen saturation 98% on room air
Section 1
As the healthcare team continues to monitor the patient, additional laboratory tests and assessments are conducted to further evaluate her condition. The initial assessment findings indicate that the patient's urine protein levels have increased significantly, confirming worsening proteinuria, a hallmark of preeclampsia. A 24-hour urine collection reveals protein excretion of 560 mg, well above the normal threshold. Blood tests show elevated liver enzymes, with AST at 48 U/L and ALT at 52 U/L, raising concerns about potential liver involvement. Platelet count is slightly decreased at 130,000/mm³, suggesting a developing risk for HELLP syndrome, a severe form of preeclampsia characterized by hemolysis, elevated liver enzymes, and low platelet count.
In addition to laboratory findings, the patient's blood pressure remains elevated despite initial attempts to manage it with lifestyle modifications and increased rest. Her blood pressure now reads 160/105 mmHg, indicating a need for pharmacological intervention. The obstetrician decides to initiate antihypertensive therapy with labetalol to reduce maternal blood pressure and minimize the risk of further complications for both mother and fetus. Given the patient's history of gestational diabetes, her blood glucose levels are closely monitored, and insulin therapy is adjusted to maintain optimal glycemic control, preventing exacerbation of her condition.
The healthcare team recognizes the potential for rapid progression of preeclampsia and closely monitors the patient for any signs of worsening symptoms, such as increasing headache severity, visual disturbances, or epigastric pain. Regular fetal assessments are conducted to evaluate the well-being of the baby, with non-stress tests and biophysical profiles providing reassurance of fetal health. The team discusses the possibility of early delivery if maternal or fetal conditions deteriorate, preparing the patient and her partner for potential induction of labor to ensure safety for both mother and child.
Section 2
As the healthcare team continues its vigilant monitoring of the patient, new diagnostic results bring additional concerns. Overnight, the patient's condition has shown signs of progression, with her blood pressure remaining persistently elevated despite the initiation of labetalol, now reading 165/110 mmHg. Additionally, the patient reports a persistent frontal headache and mild visual disturbances, which raise alarms about the potential for imminent severe complications. Repeat laboratory tests confirm a further decrease in platelet count to 115,000/mm³, while liver enzymes have risen, with AST now at 60 U/L and ALT at 68 U/L, indicating advancing HELLP syndrome. These findings, coupled with the patient's symptomatology, suggest a deterioration of her condition, necessitating swift clinical response to prevent maternal and fetal complications.
In response to these developments, the obstetric team decides to expedite the plan for delivery. The decision to proceed with induction of labor is made to mitigate the risk of severe complications such as eclampsia or liver rupture. The patient and her partner are counseled about the urgency of the situation, and they consent to the induction process with an understanding of the potential risks and benefits. Meanwhile, continuous fetal monitoring is conducted to ensure the baby's well-being, with reassuring results indicating stable fetal heart rate patterns. The healthcare team prepares to initiate induction with cervical ripening agents, followed by oxytocin infusion, while maintaining a vigilant watch for any signs of distress in either the mother or the fetus.
As the induction process begins, the multidisciplinary team remains on high alert, ready to manage any complications that may arise. Anesthesia consultation is sought to discuss pain management options, considering the patient's condition and potential need for an expedited cesarean delivery if labor does not progress as planned. The team ensures that blood products and emergency medications are readily available, underscoring the critical importance of preparedness in managing this high-risk obstetric case. The unfolding scenario requires ongoing clinical reasoning, balancing the urgency of delivery with the patient's and fetus's developing needs, and highlights the dynamic nature of managing preeclampsia with HELLP syndrome.
Section 3
As the induction process progresses, the healthcare team closely monitors the patient's response to the cervical ripening agents and oxytocin infusion. Despite the pharmacological interventions, the patient's labor fails to progress adequately, with cervical dilation remaining minimal after several hours. Her blood pressure continues to be a concern, persistently reading around 160/108 mmHg, despite maximal medical therapy with labetalol. The patient is now experiencing worsening headache and reports that her visual disturbances have intensified, further elevating the risk of eclampsia.
Given these developments, repeat laboratory tests are ordered to assess the progression of HELLP syndrome. The results reveal a further decline in platelet count to 100,000/mm³, with liver enzymes continuing to rise, as AST reaches 76 U/L and ALT climbs to 82 U/L. These laboratory findings, coupled with the patient's deteriorating clinical picture, prompt the team to reassess the situation urgently. The decision is made to transition from induction of labor to preparation for a cesarean delivery to swiftly and safely deliver the baby, mitigating the risk of severe maternal complications.
The anesthesia team is notified, and they prepare for rapid sequence induction, considering the patient's high-risk status and the potential for compromised airway management due to potential edema. The surgical team is on standby, ensuring all necessary equipment and personnel are in place for the expedited delivery. Blood products, including platelets, are prepared for immediate transfusion if needed, and the neonatal team is ready to attend to the newborn, anticipating potential issues such as respiratory distress due to preterm delivery. This coordinated effort underscores the critical importance of timely intervention and multidisciplinary collaboration in managing this complex obstetric scenario.
Section 4
As the team prepares for the cesarean delivery, the patient's condition evolves rapidly, presenting new complications that require swift clinical reasoning and action. Just before the procedure begins, the patient develops sudden onset of severe upper abdominal pain, which raises concerns for a possible hepatic hematoma or rupture, a rare but serious complication of HELLP syndrome. Her heart rate increases to 120 beats per minute, and she becomes increasingly diaphoretic and pale, indicating potential hypovolemic shock. The anesthesiologist notes that her oxygen saturation has dropped to 90% on room air, necessitating supplemental oxygen and careful airway management.
The surgical team proceeds with the cesarean delivery, recognizing the urgency of the situation to deliver the baby and address any internal complications. Blood pressure continues to be a challenge, now dropping to 98/68 mmHg, prompting the administration of intravenous fluids and preparation for blood product transfusion. During the delivery, approximately 1.5 liters of blood are noted in the abdominal cavity, confirming the suspicion of hepatic involvement. The obstetric team swiftly manages the bleeding and ensures hemostasis, while the anesthesiology team maintains hemodynamic stability through fluid resuscitation and vasopressor support.
The newborn is delivered with an initial Apgar score of 6, requiring immediate respiratory support. The neonatal team efficiently initiates positive pressure ventilation, stabilizing the infant's condition. Meanwhile, the mother receives a transfusion of packed red blood cells and platelets, stabilizing her blood pressure and improving her overall clinical status. As the surgical team completes the procedure, multidisciplinary collaboration is highlighted by the seamless coordination between obstetric, anesthesia, surgical, and neonatal care teams, ensuring both mother and baby receive the comprehensive care needed in this high-risk scenario.
Section 5
As the surgical team concludes the cesarean procedure, the focus shifts to the mother's recovery and stabilization. Despite the initial success in controlling the hemorrhage and stabilizing her hemodynamics, a new challenge emerges. The patient begins to experience increasing abdominal distension and tenderness, and her vitals reveal a slight drop in blood pressure to 94/65 mmHg with a heart rate that remains tachycardic at 115 beats per minute. Her respiratory rate increases to 24 breaths per minute, and oxygen saturation, although slightly improved with supplemental oxygen, remains at 92%. These signs suggest a possible ongoing internal bleed or the development of a secondary complication such as abdominal compartment syndrome.
Laboratory results return, showing a hemoglobin level that has dipped to 8.2 g/dL, pointing to continued blood loss or dilutional effects from fluid resuscitation. Her liver function tests show a concerning upward trend, with ALT and AST levels more than doubling since admission, indicative of potential ongoing hepatic stress or injury. The patient's platelet count has decreased further to 70,000/mm³, raising concerns for coagulopathy. The clinical team decides to perform an urgent abdominal ultrasound to assess for any undetected sources of bleeding or fluid accumulation that might account for her symptoms.
The ultrasound reveals a moderate amount of free fluid in the abdominal cavity, consistent with either residual bleeding or third-spacing due to inflammation. Given the findings and the patient's clinical status, the decision is made to return to the operating room for further exploration and possible intervention. The multidisciplinary team prepares for this procedure, ensuring that all necessary blood products are readily available and that a comprehensive plan is in place for rapid intervention. This decision underscores the critical importance of continuous assessment and the need for decisive action in the face of evolving complications, as the patient's journey through this complex and high-risk situation continues.